faa semaglutide Novo Nordisk's weight-loss pill wins FDA approval New study finds cardiovascular benefit

MeAgain App helps distinguish between these scenarios by tracking multiple progress indicators beyond weight alone

Simple timing framework Baseline Discuss baseline labs before starting, especially with diabetes, kidney disease, gallbladder history, pancreatitis history, liver disease, or cardiovascular concerns

The FDA has a drug shortage list, and injectable semaglutide was in low supply for three years, from early 2022 to February 2025

Redox Biol (2021) 43:101984

Whats the science say

Ozempic may be an option for those individuals who are diabetic, have a body mass index (BMI) that is significantly over the healthy range (27 or above), have a weight-related disease, or have cardiovascular issues in addition to weight problems